一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223523 Size: 24 KB 网页链接查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223534 Size: 24 KB 网页链接查看全文
Achaogen(AKAO)2019-07-30 08:35
$Achaogen(AKAO)$ 8-K - Current report Filed: 2019-07-29 AccNo: 0001564590-19-026635 Size: 43 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensat...查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223540 Size: 24 KB 网页链接查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments Filed: 2019-08-16 AccNo: 0001193125-19-223522 Size: 24 KB 网页链接查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-08-16 AccNo: 0001193125-19-223516 Size: 21 KB 网页链接查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ 15-12B - Securities registration termination [Section 12(b)] Filed: 2019-08-16 AccNo: 0001193125-19-223545 Size: 10 KB 网页链接查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
Achaogen(AKAO)2019-08-17 20:45
$Achaogen(AKAO)$ POS AM - Post-Effective amendments for registration statement Filed: 2019-08-16 AccNo: 0001193125-19-223513 Size: 21 KB 网页链接查看全文
E药经理人2022-10-29 00:00
以FIC估值或判断一家公司的成功与否有时也许是一个“悖论”。不能否认技术与商业之间的确存在矛盾,但真正的好药一定是追求科学价值的同时能够兑现其商业价值的。
一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen(AKAO)$ 内部交易: 2017-01-26,CFO,Schilke Tobin ,卖出,955普通股, $16.78
$Achaogen(AKAO)$ 内部交易: 2017-01-26,COO,Wise Blake ,卖出,1431普通股, $16.78
$Achaogen(AKAO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-10 AccNo: 0001144204-17-001603 Size: 109 KB 网页链接
$Achaogen(AKAO)$ 8-K - Current report Filed: 2017-01-09 AccNo: 0001301501-17-000002 Size: 21 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Achaogen(AKAO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-12-21 AccNo: 0001144204-16-140695 Size: 78 KB 网页链接
$Achaogen(AKAO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-12-22 AccNo: 0001072613-16-001012 Size: 355 KB 网页链接
$Achaogen(AKAO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-12-21 AccNo: 0001144204-16-140695 Size: 78 KB 网页链接
$Achaogen(AKAO)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-12-22 AccNo: 0001072613-16-001012 Size: 355 KB 网页链接
$Achaogen(AKAO)$ 内部交易: 2016-12-19,10% Owner,Growth Equity Opportunities IV ,买入,500000普通股, $13.50
$Achaogen(AKAO)$ 内部交易: 2016-12-19,10% Owner,BARRIS PETER J ,买入,500000普通股, $13.50